Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

@KateBeStill @minakenbo 小島氏の記事1つ目ICATTが行なった研究の論文サマリ "二価ブースターは、以前に一価ワクチンを2回、3回、または4回接種した人の症候性SARS-CoV-2感染に対する有意な追加保護を提供" 別にこれまで政府などが言ってることじゃないですか https://t.co/tq0r8t28Uv

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

RT @EmmMacfarlane: This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infect…

This statement is, in short, bullshit. There was robust evidence of the original vaccines' effectiveness *against infection*. And evidence shows bivalent vaccines provided added protection *against infection*. CDC: https://t.co/sO5IiuXmaG

@Audiotec4 @ministeriosalud @adnradiochile Estimado: creo que su fuente no es confiable. Le dejo un ej reciente de evaluación de seroneutralizacion 6 meses post-refuerzo que predice protección contra variantes omicron y link de las recomendaciones clínicas

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PREVENTED COVID. •https://t.co/RhsS2M3dOR

@KellenDomingue2 @filipe_rafaeli @schrarstzhaupt Do artigo: "These findings support the current COVID-19 vaccination policy recommending a bivalent booster dose for adults who have completed at least a primary mRNA vaccination series, irrespective of the n

@Milton06732894 Aqui está o link para o CDC, caso vc tenha preguiça de procurar no Google com base no que eu postei antes. https://t.co/6g5uZ8gftB

@Amir9999 @thevegdoc @mercurial_anna @psiklone5 @IanCopeland5 Where is your data on ineffective COVID-19 vaccines? Data shows that bivalent booster shots are effective against symtomatic infection of BA.4 and BA.5 Omicron subvariants. https://t.co/I174Vciy

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

RT @juanadiazchile: @NutrSinMarcas https://t.co/yIQ1XzdKuY

@NutrSinMarcas https://t.co/yIQ1XzdKuY

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

@DL1083 @DoctorSouz "pharma pusher man" okay dude. but for the record https://t.co/ZIbpN0pg5M https://t.co/VOleKcLtE3

RT @ENirenberg: No, this claim is disinformation actually. We now have epidemiological evidence that bivalent boosters enhance protection a…

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PREVENTED COVID. •https://t.co/RhsS2M2FZj

@Phoenix_Timber @TattyToque @DFisman Where’s the “eight mice” garbage coming from ?? Both bivalent booster were tested on over 360,000 people ……. and shown to be much more effective than the ancestral monovalent vaccine https://t.co/nI0lABQYuU

@famulare_mike @gerrythek @ENirenberg Do we have a good sense of how strong? I thought that variant mismatch and the vaccines being systemic immunization also worked against VE vs infection. E.g. Table 2 (aVE) doesn't look high (even if rVE is significant)

RT @ArtKorenevsky: I'm gonna say something really wacky here, but did you know that vaccines are still effective at preventing a fair numbe…

I'm gonna say something really wacky here, but did you know that vaccines are still effective at preventing a fair number of infections? So many, in fact, that they actually have better evidence than many NPIs... https://t.co/6ARslhSiBf https://t.co/kjmMO

@KevOnTheRanch @LizHighleyman @LauraPowellEsq My comment was RE HPV vaccines. RE bivalent SC2 vaccines which protect against COVID-19: https://t.co/yMOUWaSfiC 🐭

@Hollywood1114 @SilverFire69 @AmestoyKat @ChuckWa15503713 @kylenabecker Check the date, science changes, right? You might want to research a little more. https://t.co/KWBmQ6Oavr

@goneallweek @theJagmeetSingh In this study of immunocompetent persons tested at ICATT locations, bivalent booster doses provided significant additional protection against symptomatic SARS-CoV-2 infection. https://t.co/fDGckNlYJw.

@NoDMsHere Well considering that’s what the evidence shows yep https://t.co/o1F9E8oczM

@P_McCulloughMD @OwenShroyer @DrLoupis @VigilantFox @DrAseemMalhotra @DrKellyVictory @JonnyRoot_ @drcraigwax @12Johnstockton Hmm, guess the peer review at NEJM must be slipping. Well, here is a large analysis of Covid testing data showing that bivalent b

@iacoden @swede_irish @thereal_truther @JaneDoe69086964 https://t.co/Kx8aLaInea

ワクチン回数が多い方が感染しやすい論が統計的に間違っている この計算でその結論はないのでは？ https://t.co/9cRNOqe5Tc https://t.co/eg9nzj1kIb

ずーっと論文見てますけど　初期は一瞬効いたように見えてましたけど長い目で見た時にきちんと効いたという結論に導かれるものは出ていないと思います。

@b0yakizz ありがとうございます！ んー、先生が根拠にあげている情報を読むと、「ワクチンは有効」「2価ワクチンを含め最新のワクチンに更新する必要がある」という結論のようなので、ワクチン打つほど感染しやすいという解釈は恣意的かもですね。 https://t.co/amw1bki56C

@meimei881 日本語の方がいいですよね。こちらをどうぞ。 https://t.co/zPF8vEFf4w 海外ならいくらでもあります。まだ2価ワクチンの大がかりな報告はあまりないですけど。 https://t.co/k4bSIwyiTX https://t.co/mYGpryZmQ9

2 価(起源株/BA.4-5)ワクチン追加接種者において従来型ワクチン接種から 2~3 か月および 8 か月以上経過した者と比較した発症予防に関する有効率は、それぞれ 18~49 歳で 30%と 56%、50~64 歳で 31%と 48%、65 歳以上で 28%と 43%でした。 https://t.co/IZO20W7IzO

@2000_tantantan @MNHR_Labo 五月雨でごめんなさい。こちらはCDCの情報。 https://t.co/k4bSIwyiTX

@noncomplianz @DrSusanOliver1 @BioMedCentral As you know, the evidence is overwhelming, at all ages I’ve never taken a penny from vaccine companies There are too many papers/studies to post, but you’ll enjoy these https://t.co/pWIXUYxHIS https://t.c

@ZacharyLevi People should be free to choose whether they believe the known side effects of the vaccine are a worthy trade on their body for a vaccine that is only 56% effective for ages 18-49 — trust the science & make an informed choice https://t.co/

@blufreezy @DTSB76 @thedotconnectr @Shawncormier08 @Sir_Digby_C_S @Branth777 Covid vaccines still have efficacy. I don't care if you believe it. https://t.co/XR5j07uACA https://t.co/0sDZMjycmW

@jacobcruz123 @SniperFella @CollinRugg Do you know what effectiveness means? https://t.co/2FeoLEaryl. https://t.co/GG2rQwSEx9

@kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays It was much more effective early on with the first variant reducing infection, but the latest booster prevents around 40 to 50% of infections. https://t.co/f26xGoW6p5.

@schrodsc @kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays Early on with the original variant it was as high as 70 to 80%. Even the latest booster can be around 40 to 50%. https://t.co/f26xGoW6p5.

@Max_Fender3 @TeslaTruckClub @elonmusk @ScottAdamsSays The vaccines do a lot. Here are some of the latest results. https://t.co/f26xGoW6p5.

@Coke_Cane_Bear @kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays The original tests weren't for that, but there has been plenty of data since. If you prevent a certain percent of infections, you also prevent those people from being spreaders. https://

@beesykneezi @kouma_zaki @TeslaTruckClub @elonmusk @ScottAdamsSays Yes but there have been many studies since. If you prevent some percentage of infections, by definition you also prevent some of the spread. https://t.co/f26xGoW6p5.

@JMAC_454 @AlastairMcA30 @Ricey709 @ScottAdamsSays It is true though, we know when you are infected with a strain, you are protected primarily from that strain. The same is true for vaccination. https://t.co/Kx8aLaInea

@harald_erler @JimJamLFC @EricTopol @PLOSBiology @Prof_LDHurst @AnneF_S The vaccines were 95% effective at preventing symptomatic infection against the initial strain. They declined to about 60% vs. the same against omicron and its sublineages. The bivalen

@MarcSchaefferGD @matthewherper @Bob_Wachter @HelenBranswell efficacy PEAKED at 20-50% for the bivalent, while BA.5 was still circulating. boosting to prevent infection just isn't going to work. maybe if you get boosted once a month https://t.co/pCJxcJZa0d

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PRE…

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what? This means they PREVENTED COVID. •https://t.co/RhsS2M2FZj

#ワクチン複数回接種は有害の可能性大 感染予防効果 ほぼ無し 自然免疫生成の邪魔な 有害化の可能性大 ＞Relative vaccine effectiveness dose was 28% and 43% https://t.co/AXntQNOaHU

RT @influenzer3: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Te…

@zimsmom @CDCMMWR @GregoryRSL @_mktaylor @BeckettStephen @joshuasweitz https://t.co/iBJxUufVFr https://t.co/7uuiux1P7D https://t.co/QigiEeuOKp

RT @hfrank6048: @A352427 @tommyboy0690 https://t.co/DeCLpkby5b “bivalent boosters provided significant additional protection against sympt…

RT @hfrank6048: @A352427 @tommyboy0690 https://t.co/DeCLpkby5b “bivalent boosters provided significant additional protection against sympt…

RT @hfrank6048: @A352427 @tommyboy0690 https://t.co/DeCLpkby5b “bivalent boosters provided significant additional protection against sympt…

@A352427 @tommyboy0690 https://t.co/DeCLpkby5b “bivalent boosters provided significant additional protection against symptomatic SARS-CoV-2 infection in persons who had previously received 2, 3, or 4 monovalent vaccine doses.” DeSantis is not only wrong.

@NathanSteiner @timmullaney @FLVoiceNews Here's one specifically on the bivalent vaccine. They found it wasn't highly effective, but it was effective, especially if it had been a long time since your last dose. https://t.co/Oc7bCS7baz https://t.co/1MC9sJ

Tam sözünü ettiğiniz türden değerlendirme değil ama yine de anlamlı: This study evaluated aVE and rVE by number of previous monovalent doses received and generally found similar additional benefit of the bivalent vaccine ... https://t.co/TG6irl2HXF

@GovRonDeSantis https://t.co/dYrhj6untG

@GovRonDeSantis Idiots with no scientific expertise need to shut up about vaccines. You need to pay attention to the scientists and medical experts. https://t.co/THcbWEeX8b

@HidingoutinFL @TheBoyConker @DrCanuckMD There has been ONE bivalent vax study since Sept release. You've stated some common hearsay misinfo that's inconsistent w/ the report's findings & CDC's announcements Effectiveness of Bivalent mRNA Vaccines in

RT @carpe_diem0820: 米国での2価ワクチンの有効性報告 前回接種からの間隔の長期化で有効性↑ 重症化予防約50% Effectiveness of Bivalent mRNA Vaccines in Preventing COVID-19-Associate…

RT @j_sato: CDCの「武漢株一価💉の効果が落ちているので、オミ株二価💉を接種しよう」と呼びかける資料データから、💉の感染予防効果を算出すると ・武漢株💉2回：-26% ・武漢株💉3回：-59% ・武漢株💉4回：-76% となって、💉するほど非接種者より感染しやす…

@TheSadViolin @jumpstart1977 @mountain_ted @healthbyjames Again, let me know if the words are too big for you… https://t.co/81Mt7lA08u

@dan339g @MarkJacob16 CDC. https://t.co/Fq5UlqODgY. https://t.co/yBmO59nesF

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

@uppercasemag @EricTopol @CorsIAQ @NEJM It does stop transmission https://t.co/Drc3MZpwuZ

@joindontdie @coloradobenji It was dumb of you to think that prevents transmission meant 100% of all infections all the time. https://t.co/Drc3MZpwuZ

@BridgetVervain @flarfernutter @joindontdie They prevent transmission, just not 100% https://t.co/Drc3MZpwuZ

@flarfernutter @BridgetVervain @joindontdie They do https://t.co/Drc3MZq4kx

@joindontdie The covid vaccines do prevent transmission. https://t.co/Drc3MZpwuZ

@jbart1055 @richardzussman Bivalent vaccine is ineffective - way under 50% protection: https://t.co/p3QP8Zyl5Y

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR https://t.co/z7d2tkxWlQ

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

@bdonedone @chrislhayes The actual data shows the opposite. https://t.co/DBc2PpypIZ (Summary of above) https://t.co/11TNjj7UkI

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR https://t.co/eDxFZDG1cq

@DrPaulOffit so you‘re having an opinion while evidence points in a different direction? how original and smart. not. https://t.co/OHUWBUh2lS

@RaySahelian_MD @VeteranOfBS @jecasey3 @ninaturner https://t.co/1F5srbUnAx

@RepThomasMassie No vaccine is 100% effective. https://t.co/dTktFmTh6M via @CDCgov

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

RT @DruvBhagavan: @luckytran Per a CDC MMWR (12/2/22), the bivalent boosters offer an additional *~30-60%* protection against symptomatic i…

@MeetsLight Tässä kyseinen tutkimus. https://t.co/OE9ioKgr7e Ja tässä selitetty englanniksi: https://t.co/xC4V6nBjr4

@FellaFala @MeetsLight Löytyi useita. Katsomatta mm. Israelin data ja @DrEricDing https://t.co/AHvz4yRrY1

RT @nathan_a_tanner: @joshtpm (it is extremely clear that it helps FWIW) https://t.co/Evs24yJrBR

@joshtpm (it is extremely clear that it helps FWIW) https://t.co/Evs24yJrBR

RT @sailorrooscout: Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection. Guess what that means? Psst…

@AtomsksSanakan @Brkr_Morant @EmilyPetro22 @Covid19Ls @mauveTriforce @zipsmooch @BogusBones208 @LobotomizedM1 @GYamey @InCytometry @MaryanneDemasi @JonathanSarfat1 Emily needs to see this thread: